Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)

China · Delayed Price · Currency is CNY

9.75

+0.46 (4.95%)

Jun 29, 2026, 3:00 PM CST

-11.60% (1Y)

Market Cap	17.40B -13.7%
Revenue (ttm)	14.85B -3.4%
Net Income	1.31B -4.9%
EPS	0.73 -0.6%
Shares Out	1.78B
PE Ratio	13.40
Forward PE	12.19
Dividend	0.22 (2.37%)
Ex-Dividend Date	Jun 26, 2026

Volume	20,547,541
Open	9.25
Previous Close	9.29
Day's Range	9.08 - 9.77
52-Week Range	9.28 - 14.21
Beta	0.19
Analysts	Strong Buy
Price Target	15.74 (+61.44%)
Earnings Date	Aug 24, 2026

About SHA:600380

Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and traditional Chinese medicine, including cold medicine anti-viral granules and anti-tumor medicine. It also provides diagnostic reagents and equipment, such ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1992

Employees 13,575

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600380

Full Company Profile

Financial Performance

In 2025, SHA:600380's revenue was 15.22 billion, a decrease of -2.58% compared to the previous year's 15.62 billion. Earnings were 1.34 billion, a decrease of -3.68%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 600380 stock is "Strong Buy." The 12-month stock price target is ¥15.74, which is an increase of 61.44% from the latest price.

Price Target

¥15.74

(61.44% upside)

Analyst Consensus: Strong Buy

Stock Forecasts